Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations
Open Access
- 11 April 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 17 (1), 99
- https://doi.org/10.1186/s13075-015-0613-6
Abstract
To determine the prevalence and clinical/laboratory associations of subclinical atherosclerosis and impaired bone health in primary Sjogren’s syndrome (SS). 64 consecutive patients with primary SS, 77 with rheumatoid arthritis (RA) and 60 healthy controls (HC) οf similar age and sex distribution were enrolled. Demographics, clinical/laboratory features, classical risk factors for atherosclerosis and osteoporosis (OP) were recorded. Intima-medial thickness scores (IMT) and carotid/femoral (C/F) plaque formation, as well as bone mineral density (BMD) and fractures were evaluated. Determinants of IMT/BMD levels and the presence of plaque were assessed by univariate and multivariate models. Serum levels of the Wnt signaling mediators Dickkopf-related protein 1(DKK1) and sclerostin were determined in primary SS patients and HC. Increased arterial wall thickening (IMT > 0.90 mm) and impaired bone health (defined as OP or osteopenia), were detected in approximately two-thirds of primary SS and RA patients, with a mean IMT value being significantly increased compared to HC. The presence of primary SS emerged as an independent risk factor for arterial wall thickening when traditional risk factors for cardiovascular disease (CVD) including age, sex, hypertension, smoking (pack/years), LDL and HDL levels were taken into account in a multivariate model [adjusted OR 95% (CI): 2.8 (1.04-7.54)]. In primary SS, age was revealed as independent predictor of increased IMT scores; age and lymphopenia as well as increased urine pH as independent determinants of C/F plaque formation and OP/osteopenia, respectively. An independent association of OP/osteopenia with plaque formation was observed when independent predictors for both variables were considered, with low DKK1 levels being associated with both plaque formation and lower BMD levels. Comorbidities such as subclinical atherosclerosis and impaired bone health occur frequently in primary SS, in association with disease related features and traditional risk factors. Wnt signaling mediators are potentially involved in the pathogenesis of both entities. The online version of this article (doi:10.1186/s13075-015-0613-6) contains supplementary material, which is available to authorized users.Keywords
This publication has 54 references indexed in Scilit:
- Increased risk of osteoporosis and fracture in women with systemic sclerosis: A comparative study with rheumatoid arthritisArthritis Care & Research, 2012
- Primary biliary cirrhosis and Sjögren’s syndrome: Autoimmune epithelitisJournal of Autoimmunity, 2012
- Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial StiffnessCalcified Tissue International, 2012
- Subclinical Atherosclerosis and Endothelial Dysfunction in Patients with Early Rheumatoid Arthritis as Evidenced by Measurement of Carotid Intima-Media Thickness and Flow-Mediated Vasodilatation: An Observational StudySeminars in Arthritis and Rheumatism, 2012
- Systemic Lupus Erythematosus With Sjögren Syndrome Compared to Systemic Lupus Erythematosus AloneJCR: Journal of Clinical Rheumatology, 2012
- Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritisArthritis & Rheumatism, 2011
- Osteoporosis: now and the futureThe Lancet, 2011
- Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoidsOsteoporosis International, 2011
- (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosisArthritis Research & Therapy, 2011
- How does interferon-α insult the vasculature? Let me count the waysArthritis & Rheumatism, 2010